Bruker debuts MyGenius PRO
- Bruker introduced MyGenius PRO, an automated PCR diagnostics platform, at ESCMID 2026. - The platform targets automated infectious‑disease PCR workflows and on‑bench automation. - Automated PCR platforms typically change accessory, sample‑handling, and validation needs for clinical labs (x.com).
Bruker used ESCMID Global 2026 in Munich to launch MyGenius PRO, a new automated PCR system for infectious-disease testing in Europe. (bruker.com) PCR, short for polymerase chain reaction, is a lab method that copies tiny amounts of genetic material until a virus, bacterium, or fungus can be detected. MyGenius PRO is built as a “sample-to-answer” machine, meaning one instrument is meant to take a patient specimen through processing and produce a result. (bruker.com) Bruker said the system is designed for medium- to high-volume labs, can deliver up to 144 results in about eight hours, and can produce a first result in 100 minutes. The company also said the platform supports continuous loading of samples, consumables, and reagents, plus random-access operation so labs do not have to wait for one full batch before starting another. (elitechgroup.com) The launch lands at ESCMID Global 2026, the European Society of Clinical Microbiology and Infectious Diseases meeting running April 17-21 at Messe München. That conference is a major showcase for new diagnostics aimed at hospital microbiology and infectious-disease labs. (escmid.org) For clinical labs, a new automated PCR box is not just a faster analyzer. It can change how specimens are loaded, which consumables and extraction steps are needed, how staff divide work on the bench, and what validation studies are required before routine patient testing begins. (elitechgroup.com) Bruker said one MyGenius PRO system is already installed at “a leading European transplant center” for routine infectious-disease testing. The company also said it plans menu expansion through 2026, including assays for Human Immunodeficiency Virus type 1, Hepatitis B virus, Hepatitis C virus, and Human Herpesvirus 6 under Europe’s In Vitro Diagnostic Regulation framework. (businesswire.com) The platform was developed with ELITechGroup, a Bruker company, and Hitachi High-Tech, which Bruker said contributed automation and engineering expertise. Bruker positioned MyGenius PRO as the higher-throughput sibling to its existing InGenius and BeGenius molecular systems. (morningstar.com) Bruker’s pitch is straightforward: move more infectious-disease PCR work into one automated workflow, with fewer manual handoffs between sample and result. Whether labs adopt it widely will depend on assay menu, regulatory fit, workflow changes, and the validation work each site still has to do. (bruker.com)
